Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Medullary × fludarabine × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 214 Precursor Cell Lymphoblastic Leukemia-Lymphoma 129 Myelodysplastic Syndromes 126 Leukemia, Lymphocytic, Chronic, B-Cell 126 Leukemia 114 Multiple Myeloma 107 Lymphoma 106 Lymphoma, Non-Hodgkin 104 Hematologic Neoplasms 69 Recurrence 66 Melanoma 64 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 64 Hodgkin Disease 64 Lymphoma, B-Cell 56 Lymphoma, Mantle-Cell 48 Lymphoma, Follicular 48 Lymphoma, Large B-Cell, Diffuse 46 Myeloproliferative Disorders 39 Burkitt Lymphoma 38 Ovarian Neoplasms 36 Neoplasms 35 Neoplasm Metastasis 28 Lymphoma, B-Cell, Marginal Zone 28 Graft vs Host Disease 26 Leukemia, Biphenotypic, Acute 25 Breast Neoplasms 25 Carcinoma, Non-Small-Cell Lung 24 Primary Myelofibrosis 23 Neoplasms, Plasma Cell 23 Pancreatic Neoplasms 20

Interventions

vandetanib 14 cabozantinib 8 selpercatinib 6 Everolimus 5 Sorafenib 4 Magnetic Resonance Spectroscopy 3 Capecitabine 3 sargramostim 2 pralsetinib 2 lutetium Lu 177 dotatate 2 lenvatinib 2 Trastuzumab 2 Temozolomide 2 Sunitinib 2 Octreotide 2 Gefitinib 2 yeast-CEA vaccine 1 veliparib 1 vatalanib 1 tumor necrosis factor-alpha, CNGRC fusion protein, human 1 tipifarnib 1 temsirolimus 1 tanespimycin 1 sacubitril and valsartan sodium hydrate drug combination 1 ponatinib 1 pentetreotide 1 pembrolizumab 1 pazopanib 1 pasireotide 1 nintedanib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04877613 2025-07-03

GFRα4 CAR T Cells in MTC Patients

University of Pennsylvania

Phase 1 Active not recruiting

Carcinoma, Medullary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡